These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2886201)

  • 1. Diabetes alters the reactivity of myocardium to a thromboxane analogue.
    Canga L; Gorelik G; Sterin-Borda L
    Can J Physiol Pharmacol; 1987 Apr; 65(4):499-503. PubMed ID: 2886201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The positive inotropic effect of sodium arachidonate on auricles from diabetic rats.
    Canga L; Sterin-Borda L; Borda ES; Peredo H; Gimeno AL
    Eur J Pharmacol; 1985 Mar; 110(1):47-54. PubMed ID: 3924636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in atrial contractility induced by PGE2 in diabetic rats.
    Canga L; Sterin-Borda L
    Pharmacol Res Commun; 1986 Apr; 18(4):371-84. PubMed ID: 2874571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal vascular responsiveness to arachidonic acid in experimental diabetes.
    Quilley J; McGiff JC
    Br J Pharmacol; 1990 Jun; 100(2):336-40. PubMed ID: 2116203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive inotropic effect of the thromboxane analog U-46619 on guinea pig left atrium: mediation by specific receptors and association with increased phosphoinositide turnover.
    Sakuma I; Gross SS; Levi R
    Can J Physiol Pharmacol; 1989 Aug; 67(8):943-9. PubMed ID: 2557146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity to methoxamine in atria isolated from streptozotocin-induced diabetic rats.
    Canga L; Sterin-Borda L
    Br J Pharmacol; 1986 Jan; 87(1):157-65. PubMed ID: 2869807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential response of postischemic diabetic myocardium to a thromboxane-mimetic.
    Pieper GM; Gross GJ
    Eicosanoids; 1990; 3(3):127-33. PubMed ID: 2242272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of rat thoracic aortic rings to thromboxane mimetic U-46,619: roles of endothelium-derived relaxing factor and thromboxane A2 release.
    Folger WH; Lawson D; Wilcox CS; Mehta JL
    J Pharmacol Exp Ther; 1991 Aug; 258(2):669-75. PubMed ID: 1865363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin (PGI2) and U-46619 stimulate coronary arteries from diabetic dogs and their action is influenced by inhibitors of prostaglandin biosynthesis.
    Sterin-Borda L; Gimeno M; Borda E; del Castillo E; Gimeno AL
    Prostaglandins; 1981 Aug; 22(2):267-78. PubMed ID: 7027326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of U46619 and of inhibitors of the synthesis of TXA2 on insulin action on the metabolism of labelled glucose in uteri isolated from ovariectomized-diabetic rats.
    Gonzalez E; Franchi AM; Jawerbaum A; Gimeno AL; Gimeno MA
    Prostaglandins; 1994 Sep; 48(3):129-37. PubMed ID: 7809380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of renin by thromboxane: studies with thromboxane synthase inhibitor, receptor antagonists, and mimetic.
    Welch WJ; Wilcox CS; Dunbar KR
    Am J Physiol; 1989 Oct; 257(4 Pt 2):F554-60. PubMed ID: 2508488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TXB2: cardiostimulant effect that involves beta-adrenoceptor and Na+ + K+-ATPase activity.
    Pascual J; Sterin-Borda L; Wald M; Borda ES
    Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):53-9. PubMed ID: 2847200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of thromboxane A2 in bradykinin-induced human isolated small bronchi contraction.
    Molimard M; Martin CA; Naline E; Hirsch A; Advenier C
    Eur J Pharmacol; 1995 May; 278(1):49-54. PubMed ID: 7545124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug induced inhibition of the cardiac effects of U 46619 as a thromboxane A2-like agonist.
    Mentz P; Pawelski KE; Giessler C
    Biomed Biochim Acta; 1984; 43(8-9):S163-6. PubMed ID: 6517896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metabolized and unmetabolized arachidonate on rat platelet shape change.
    Lampugnani MG; de Gaetano G
    Am J Physiol; 1984 Sep; 247(3 Pt 2):H440-5. PubMed ID: 6433724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thromboxane A2 on lymphocyte proliferation.
    Ceuppens JL; Vertessen S; Deckmyn H; Vermylen J
    Cell Immunol; 1985 Feb; 90(2):458-63. PubMed ID: 3155656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in cardiovascular sensitivity of alloxan-treated diabetic rats to arachidonic acid.
    Boura AL; Hodgson WC; King RG
    Br J Pharmacol; 1986 Nov; 89(3):613-8. PubMed ID: 3099877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thromboxane responses in the airway of the cat by SQ29,548 and OKY 1581.
    Kadowitz PJ; McNamara DB; Tilden SJ; Hyman AL; Underwood DC
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():535-8. PubMed ID: 2526533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.